The impact of radiotherapy on cognitive development in pediatric patients with CNS tumor

Authors

  • Marco Departamento das Ciências do Diagnóstico, Terapêutica e Saúde Pública, Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.
  • Rita Correia Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.
  • Rute Martins Escola Superior de Tecnologia da Saúde de Lisboa, Instituto Politécnico de Lisboa. Lisboa, Portugal.

DOI:

https://doi.org/10.25758/set.835

Keywords:

Radiotherapy, Pediatrics, Central nervous system, Brain tumors, Cognitive effects, IQ

Abstract

Introduction Central nervous system (CNS) tumors are the second most common malignancy and the leading cause of cancer-related death in children and adolescents under the age of 20 years. Although therapeutic advances have increased the 5-year survival rate to approximately 80 percent, treatments still cause acute and late adverse effects. The acute effects of radiotherapy (RT) include fatigue, nausea, vomiting, and headaches, while late effects include neurological and cognitive deficits that affect the quality of life. This study analyzed the late cognitive side effects of RT in pediatric patients with tumors of the central nervous system, an area that has not been explored in the scientific literature. Objectives To identify the cognitive effects and understand their impact on the development of central nervous system tumors in pediatric patients undergoing RT. Methods A systematic literature review was conducted following the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), and a systematic literature review was carried out. The search for scientific literature was carried out in December 2023 in the PubMed/MEDLINE, Scopus, and Web of Science databases according to the inclusion and exclusion criteria defined by PEOS. Results A total of 25 articles were obtained, demonstrating changes in cognitive level, academic performance, and IQ. In addition, other factors, such as endocrine alterations and hearing loss, were identified. Conclusion RT impacts the development and quality of life of patients, leading to various late cognitive effects. The identified effects were neuropsychological, neurocognitive, cognitive, and intellectual deficits, in executive function, difficulties in social integration, and carrying out daily activities, worse academic performance, processing speed, memory, attention problems, and a lower IQ.  

Downloads

Download data is not yet available.

References

Pancaldi A, Pugliese M, Migliozzi C, Blom J, Cellini M, Iughetti L. Neuropsychological outcomes of children treated for brain tumors. Children (Basel). 2023;10(3):472.

Srsich AR, McCurdy MD, Fantozzi PM, Hocking MC. Predicting neuropsychological late effects in pediatric brain tumor survivors using the Neurological Predictor Scale and the Pediatric Neuro-Oncology Rating of Treatment Intensity. J Int Neuropsychol Soc. 2024;30(4):380-8.

Roddy E, Mueller S. Late effects of treatment of pediatric central nervous system tumors. J Child Neurol. 2016;31(2):237-54.

Suneja G, Poorvu PD, Hill-Kayser C, Lustig RA. Acute toxicity of proton beam radiation for pediatric central nervous system malignancies. Pediatr Blood Cancer. 2013;60(9):1431-6.

Jimenez RB, Ahmed S, Johnson A, Thomas H, Depauw N, Horick N, et al. Proton radiation therapy for pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys. 2021;110(5):1480-7.

Song S, Park HJ, Yoon JH, Kim DW, Park J, Shin D, et al. Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors. Acta Oncol. 2014;53(9):1158-64.

Lőcsei Z, Farkas R, Farkas KB, Sebestyén K, Sebestyén Z, Musch Z, et al. Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five years. BMC Cancer. 2020;20(1):702.

Lenzen A, Sosa RM, Habiby R, DiPatri Jr AJ, Smiley NP. Pediatric central nervous system tumor diagnosis, complications, and emergencies. Clin Pediatr Emerg Med. 2018;19(2):153-61.

Beijer JG, Kok JL, Janssens GO, Streefkerk N, de Vries AC, Slagter C, et al. Adverse late health outcomes among children treated with 3D radiotherapy techniques: study design of the Dutch pediatric 3D-RT study. Cancer Rep (Hoboken). 2023;6(2):e1620.

Zaghloul MS, Eldebawy E, Ahmed S, Mousa AG, Amin A, Refaat A, et al. Hypofractionated conformal radiotherapy for pediatric diffuse intrinsic pontine glioma (DIPG): a randomized controlled trial. Radiother Oncol. 2014;111(1):35-40.

Önal G, Huri M. Cognitive functions of children with brain tumor in the treatment process. Br J Occup Ther. 2021;84(3):164-72.

Nguyen T, Mueller S, Malbari F. Review: Neurological complications from therapies for pediatric brain tumors. Front Oncol. 2022;12:853034.

Seidel C, Heider S, Hau P, Glasow A, Dietzsch S, Kortmann RD. Radiotherapy in medulloblastoma: evolution of treatment, current concepts and future perspectives. Cancers (Basel). 2021;13(23):5945.

Alessi I, Caroleo AM, de Palma L, Mastronuzzi A, Pro S, Colafati GS, et al. Short and long-term toxicity in pediatric cancer treatment: central nervous system damage. Cancers (Basel). 2022;14(6):1540.

Foster M, Kamaly-Asl I, Stivaros S, Kelsey A, Gattamenini R, Kilday JP. Primary cerebral histiocytic sarcoma in childhood: a case report of protracted survival and review of the literature. Childs Nerv Syst. 2015;31(12):2363-8.

McAleer MF, Brown PD. Neurocognitive function following therapy for low-grade gliomas. Semin Radiat Oncol. 2015;25(3):210-8.

Gordon D, Maria BL. Molecular advances and targeted therapies for pediatric central nervous system tumors. J Child Neurol. 2021;36(1):5-29.

Michiels EM, Schouten-Van Meeteren AY, Doz F, Janssens GO, van Dalen EC. Chemotherapy for children with medulloblastoma. Cochrane Database Syst Rev. 2015;1(1):CD006678.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Munn Z, Stern C, Aromataris E, Lockwood C, Jordan Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018;18(1):5.

Dhammi IK, Kumar S. Medical subject headings (MeSH) terms. Indian J Orthop. 2014;48(5):443-4.

Pereira VG, Utagawa CY, Gambarato BC. O uso de descritores em artigos científicos na área de educação em saúde [The use of subject headings in scientific articles in the field of health education]. Rev Saúde Dig Tecnol Educ. 2018;3(1):27-40. Portuguese

Álvares M. Introdução à investigação quantitativa e análise SPSS [Internet]. Lisboa: Universidade Aberta; 2021. Available from: http://hdl.handle.net/10400.2/10529

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan: a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.

Hawker S, Payne S, Kerr C, Hardey M, Powell J. Appraising the evidence: reviewing disparate data systematically. Qual Health Res. 2002;12(9):1284-99.

Moxon-Emre I, Dahl C, Ramaswamy V, Bartels U, Tabori U, Huang A, et al. Hearing loss and intellectual outcome in children treated for embryonal brain tumors: implications for young children treated with radiation sparing approaches. Cancer Med. 2021;10(20):7111-25.

Fortin D, Tsang D, Ng A, Laperriere N, Hodgson DC. Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients. J Neurooncol. 2017;135(3):521-8.

Carroll C, Watson P, Spoudeas HA, Hawkins MM, Walker DA, Clare IC, et al. Prevalence, associations, and predictors of apathy in adult survivors of infantile (<5 years of age) posterior fossa brain tumors. Neuro Oncol. 2013;15(4):497-505.

Wagner AP, Carroll C, White SR, Watson P, Spoudeas HA, Hawkins MM, et al. Long-term cognitive outcome in adult survivors of an early childhood posterior fossa brain tumour. Int J Clin Oncol. 2020;25(10):1763-73.

Baudou E, Pariente J, Péran P, Tensaouti F, Pollidoro L, Meligne D, et al. A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence. Clin Transl Radiat Oncol. 2021;33:7-14.

Limond J, Thomas S, Bull KS, Calaminus G, Lemiere J, Traunwieser T, et al. Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years. Eur J Paediatr Neurol. 2020;25:59-67.

Doger de Speville E, Robert C, Perez-Guevara M, Grigis A, Bolle S, Pinaud C, et al. Relationships between regional radiation doses and cognitive decline in children treated with cranio-spinal irradiation for posterior fossa tumors. Front Oncol. 2017;7:166.

Corti C, Urgesi C, Massimino M, Gandola L, Bardoni A, Poggi G. Effects of supratentorial and infratentorial tumor location on cognitive functioning of children with brain tumor. Childs Nerv Syst. 2020;36(3):513-24.

Toussaint L, Indelicato DJ, Stokkevåg CH, Lassen-Ramshad Y, Pedro C, Mikkelsen R, et al. Radiation doses to brain substructures associated with cognition in radiotherapy of pediatric brain tumors. Acta Oncol. 2019;58(10):1457-62.

McClellan W, Klemp JR, Krebill H, Ryan R, Nelson EL, Panicker J, et al. Understanding the functional late effects and informational needs of adult survivors of childhood cancer. Oncol Nurs Forum. 2013;40(3):254-62.

Mash LE, Kahalley LS, Okcu MF, Grosshans DR, Paulino AC, Stancel H, et al. Superior verbal learning and memory in pediatric brain tumor survivors treated with proton versus photon radiotherapy. Neuropsychology. 2023;37(2):204-17.

Kline C, Stoller S, Byer L, Samuel D, Lupo JM, Morrison MA, et al. An integrated analysis of clinical, genomic, and imaging features reveals predictors of neurocognitive outcomes in a longitudinal cohort of pediatric cancer survivors, enriched with CNS tumors (Rad ART Pro). Front Oncol. 2022;12:874317.

Unnikrishnan S, Yip AT, Qian AS, Salans MA, Yu JD, Huynh-Le MP, et al. Neurocognitive outcomes in multiethnic pediatric brain tumor patients treated with proton versus photon radiation. J Pediatr Hematol Oncol. 2023;45(7):e837-46.

Roth AK, Ris MD, Orobio J, Xue J, Mahajan A, Paulino AC, et al. Cognitive mediators of adaptive functioning outcomes in survivors of pediatric brain tumors treated with proton radiotherapy. Pediatr Blood Cancer. 2020;67(2):e28064.

Yecies D, Azad TD, Esparza R, Quon JL, Forkert ND, MacEachern SJ, et al. Long-term supratentorial radiologic effects of surgery and local radiation in children with infratentorial ependymoma. World Neurosurg. 2019;122:e1300-4.

Robinson KE, Pearson MM, Cannistraci CJ, Anderson AW, Kuttesch JF, Wymer K, et al. Neuroimaging of executive function in survivors of pediatric brain tumors and healthy controls. Neuropsychology. 2014;28(5):791-800.

Ventura LM, Grieco JA, Evans CL, Kuhlthau KA, MacDonald SM, Tarbell NJ, et al. Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy. J Neurooncol. 2018;137(1):119-26.

Agbahiwe H, Rashid A, Horska A, Mahone EM, Lin D, McNutt T, et al. A prospective study of cerebral, frontal lobe, and temporal lobe volumes and neuropsychological performance in children with primary brain tumors treated with cranial radiation. Cancer. 2017;123(1):161-8.

Mash LE, Kahalley LS, Raghubar KP, Goodrich-Hunsaker NJ, Abildskov TJ, De Leon LA, et al. Cognitive sparing in proton versus photon radiotherapy for pediatric brain tumor is associated with white matter integrity: an exploratory study. Cancers (Basel). 2023;15(6):1844.

Eaton BR, Fong GW, Ingerski LM, Pulsifer MB, Goyal S, Zhang C, et al. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma. Cancer. 2021;127(20):3840-6.

Moxon-Emre I, Taylor MD, Bouffet E, Hardy K, Campen CJ, Malkin D, et al. Intellectual outcome in molecular subgroups of medulloblastoma. J Clin Oncol. 2016;34(34):4161-70.

Zureick AH, Evans CL, Niemierko A, Grieco JA, Nichols AJ, Fullerton BC, et al. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors. Cancer. 2018;124(10):2238-45.

Landau E, Boop FA, Conklin HM, Wu S, Xiong X, Merchant TE. Supratentorial ependymoma: disease control, complications, and functional outcomes after irradiation. Int J Radiat Oncol Biol Phys. 2013;85(4):e193-9.

Redmond KJ, Hildreth M, Sair HI, Terezakis S, McNutt T, Kleinberg L, et al. Association of neuronal injury in the genu and body of corpus callosum after cranial irradiation in children with impaired cognitive control: a prospective study. Int J Radiat Oncol Biol Phys. 2018;101(5):1234-42.

Armstrong GT, Reddick WE, Petersen RC, Santucci A, Zhang N, Srivastava D, et al. Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy. J Natl Cancer Inst. 2013;105(12):899-907.

Ottensmeier H, Zimolong B, Wolff JE, Ehrich J, Galley N, von Hoff K, et al. Neuropsychological short assessment of disease- and treatment-related intelligence deficits in children with brain tumours. Eur J Paediatr Neurol. 2015;19(3):298-307.

Weusthof K, Lüttich P, Regnery S, König L, Bernhardt D, Witt O, et al. Neurocognitive outcomes in pediatric patients following brain irradiation. Cancers (Basel). 2021;13(14):3538.

Lassaletta A, Bouffet E, Mabbott D, Kulkarni AV. Functional and neuropsychological late outcomes in posterior fossa tumors in children. Childs Nerv Syst. 2015;31(10):1877-90.

Schreiber JE, Gurney JG, Palmer SL, Bass JK, Wang M, Chen S, et al. Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma. Neuro Oncol. 2014;16(8):1129-36.

Heitzer AM, Villagran AM, Raghubar K, Brown AL, Camet ML, Ris MD, et al. Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor. J Neurooncol. 2020;146(1):147-56.

Sleurs C, Jacobs S, Counsell SJ, Christiaens D, Tournier JD, Sunaert S, et al. Brain network hubs and cognitive performance of survivors of childhood infratentorial tumors. Radiother Oncol. 2021;161:118-25.

Tso WW, Hui ES, Lee TM, Liu AP, Ip P, Vardhanabhuti V, et al. Brain microstructural changes associated with neurocognitive outcome in intracranial germ cell tumor survivors. Front Oncol. 2021;11:573798.

Docking KM, Knijnik SR. Prospective longitudinal decline in cognitive-communication skills following treatment for childhood brain tumor. Brain Inj. 2021;35(11):1472-9.

Published

2025-03-25

Issue

Section

Artigos de Revisão

How to Cite

The impact of radiotherapy on cognitive development in pediatric patients with CNS tumor. (2025). Saúde & Tecnologia, 30, e835. https://doi.org/10.25758/set.835